hydroxyproline has been researched along with baicalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DR; Choi, YK; Kim, JW; Kwon, HS; Park, YK; Yang, EG | 1 |
| Che, QM; Pu, XP; Sun, H; Zhao, X | 1 |
| Chen, Y; Gao, Y; Gu, Z; Jiang, X; Lu, J; Zhang, Y | 1 |
3 other study(ies) available for hydroxyproline and baicalein
| Article | Year |
|---|---|
Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Topics: Amino Acid Sequence; Enzyme Inhibitors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Peptides; Procollagen-Proline Dioxygenase; Substrate Specificity | 2011 |
Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Down-Regulation; Fibrillar Collagens; Flavanones; Hyaluronic Acid; Hydroxyproline; Laminin; Liver; Liver Cirrhosis; Liver Function Tests; Male; Matrix Metalloproteinases; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Time Factors | 2010 |
Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21.
Topics: Actins; Administration, Oral; Animals; Antioxidants; Bleomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Flavanones; Hydroxyproline; Male; MicroRNAs; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2013 |